UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

Hematological oncology, 2023-06, Vol.41 (S2), p.87-88

2023

Volltextzugriff (PDF)

Immunohistochemistry in Kaposi's sarcoma

Clinical and experimental dermatology, 2010-01, Vol.35 (1), p.68-72

2010

Volltextzugriff (PDF)

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

The New England journal of medicine, 1997-06, Vol.336 (23), p.1641-1648

1997

Volltextzugriff (PDF)

S207: EFFICACY AND SAFETY OF A THIRD GENERATION CD20 CART (MB‐106) FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL)

HemaSphere, 2022-06, Vol.6, p.108-109

2022

Volltextzugriff (PDF)

Kaposi's sarcoma and pemphigus

Journal of the European Academy of Dermatology and Venereology, 2007-04, Vol.21 (4), p.571-572

2007

Volltextzugriff (PDF)

Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma

Journal of investigative dermatology, 1999-12, Vol.113 (6), p.1047-1053

1999

Volltextzugriff (PDF)

The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients

The Journal of experimental medicine, 1996-07, Vol.184 (1), p.283-288

1996

Volltextzugriff (PDF)

Kaposi's sarcoma: a model of both malignancy and chronic inflammation

Panminerva medica, 2007-09, Vol.49 (3), p.119

2007

Volltextzugriff (PDF)

Expression of Tie1, Tie2, and Angiopoietins 1, 2, and 4 in Kaposi's Sarcoma and Cutaneous Angiosarcoma

The American journal of pathology, 2000-06, Vol.156 (6), p.2179-2183

2000

Volltextzugriff (PDF)

Three Inhibitors of Type 1 Human Immunodeficiency Virus Long Terminal Repeat-Directed Gene Expression and Virus Replication

Proceedings of the National Academy of Sciences - PNAS, 1993-03, Vol.90 (5), p.1839-1842

1993

Volltextzugriff (PDF)

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma

Journal of clinical oncology, 1998-02, Vol.16 (2), p.683-691

1998

Volltextzugriff (PDF)

Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma—Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease

Clinical infectious diseases, 2008-11, Vol.47 (9), p.1209-1215

2008

Volltextzugriff (PDF)

The Kaposi's Sarcoma-Associated Herpesvirus K12 Transcript from a Primary Effusion Lymphoma Contains Complex Repeat Elements, Is Spliced, and Initiates from a Novel Promoter

Journal of Virology, 2002-12, Vol.76 (23), p.11880-11888

2002

Volltextzugriff (PDF)

High Resolution Anoscopy Findings for Men Who Have Sex with Men: Inaccuracy of Anal Cytology as a Predictor of Histologic High-Grade Anal Intraepithelial Neoplasia and the Impact of HIV Serostatus

Clinical infectious diseases, 2004-05, Vol.38 (10), p.1495-1497

2004

Volltextzugriff (PDF)

CLINICAL PRESENTATION AND NATURAL HISTORY OF AIDS-RELATED KAPOSI'S SARCOMA

Hematology/oncology clinics of North America, 1996-10, Vol.10 (5), p.1023-1029

Dezube, Bruce J.

1996

Volltextzugriff (PDF)

Pentoxifylline for the Treatment of Infection with Human Immunodeficiency Virus

Clinical infectious diseases, 1994-03, Vol.18 (3), p.285-287

Dezube, Bruce J.

1994

Volltextzugriff (PDF)

1027MO ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)

Annals of oncology, 2020-09, Vol.31, p.S708-S709

2020

Volltextzugriff (PDF)

The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu

Seminars in oncology, 2000-08, Vol.27 (4), p.420-423

Dezube, B J

2000

Volltextzugriff (PDF)

Topacio: Preliminary activity and safety in patients (pts) with platinum-resistant ovarian cancer (PROC) in a phase 1/2 study of niraparib in combination with pembrolizumab

Gynecologic oncology, 2018-06, Vol.149, p.246-246

2018

Volltextzugriff (PDF)

Fumagillin analog in the treatment of Kaposi's sarcoma : A phase I AIDS clinical trial group study

Journal of clinical oncology, 1998-04, Vol.16 (4), p.1444-1449

1998

Volltextzugriff (PDF)

Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium

Genes & cancer, 2012-07, Vol.3 (7-8), p.512-520

2012

Volltextzugriff (PDF)

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Hematological oncology, 2023-06, Vol.41 Suppl 2, p.87

2023

Volltextzugriff (PDF)

Dose-finding combination study of niraparib and pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or recurrent platinum-resistant epithelial ovarian cancer (OC) (TOPACIO/Keynote-162)

Annals of oncology, 2017-09, Vol.28, p.v406-v407

2017

Volltextzugriff (PDF)

New therapies for the treatment of AIDS-related Kaposi sarcoma

Current opinion in oncology, 2000-09, Vol.12 (5), p.445-449

Dezube, Bruce J

2000

Volltextzugriff (PDF)

Abstract PD5-02: Durability of clinical benefit with niraparib + pembrolizumab in patients with advanced triple-negative breast cancer beyond BRCA : (TOPACIO/Keynote-162)

Cancer research (Chicago, Ill.), 2019-02, Vol.79 (4_Supplement), p.PD5-02-PD5-02

2019

Volltextzugriff (PDF)

1 – 25 von 138

Suche als RSS-Feed

Aktive Filter

ThemaMale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(117)
Mit Volltextzugriff
(119)

Publikationsform

Artikel
(136)
Berichte
(2)

Sprache

Englisch
(138)

Erscheinungsjahr

n.n

Thema

Science & Technology
(59)
Life Sciences & Biomedicine
(55)
Humans
(50)
Biological And Medical Sciences
(37)
Medical Sciences
(37)
Pharmacology. Drug Treatments
(21)
Aids/hiv
(19)
Oncology
(17)
Infectious Diseases
(14)
Acquired Immunodeficiency Syndrome - Complications
(11)
Hiv
(11)
Antiviral Agents
(10)
Immunology
(10)
Dermatology
(9)
Human Immunodeficiency Virus 1
(9)
Microbiology
(9)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(8)
Antineoplastic Agents
(8)
Base Sequence
(8)
Hiv-1 - Genetics
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HIGH EFFICACY AND FAVORABLE SAFETY OF 3RD GENERATION CD20 CAR‐T (MB‐106) FOR OUTPATIENT TREATMENT OF FOLLICULAR LYMPHOMA (FL)—RESULTS OF A SINGLE‐INSTITUTION TRIAL

Immunohistochemistry in Kaposi's sarcoma

Low-Dose Compared with Standard-Dose m-BACOD Chemotherapy for Non-Hodgkin's Lymphoma Associated with Human Immunodeficiency Virus Infection

S207: EFFICACY AND SAFETY OF A THIRD GENERATION CD20 CART (MB‐106) FOR TREATMENT OF RELAPSED/REFRACTORY FOLLICULAR LYMPHOMA (FL)

Kaposi's sarcoma and pemphigus

Vascular Endothelial Growth Factor-C (VEGF-C) and its Receptors KDR and flt-4 are Expressed in AIDS-Associated Kaposi’s Sarcoma

The Kaposi sarcoma-associated herpesvirus (KSHV) is present as an intact latent genome in KS tissue but replicates in the peripheral blood mononuclear cells of KS patients

Kaposi's sarcoma: a model of both malignancy and chronic inflammation

Expression of Tie1, Tie2, and Angiopoietins 1, 2, and 4 in Kaposi's Sarcoma and Cutaneous Angiosarcoma

Three Inhibitors of Type 1 Human Immunodeficiency Virus Long Terminal Repeat-Directed Gene Expression and Virus Replication

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma

Epidemiology, Pathophysiology, and Treatment of Kaposi Sarcoma—Associated Herpesvirus Disease: Kaposi Sarcoma, Primary Effusion Lymphoma, and Multicentric Castleman Disease

The Kaposi's Sarcoma-Associated Herpesvirus K12 Transcript from a Primary Effusion Lymphoma Contains Complex Repeat Elements, Is Spliced, and Initiates from a Novel Promoter

High Resolution Anoscopy Findings for Men Who Have Sex with Men: Inaccuracy of Anal Cytology as a Predictor of Histologic High-Grade Anal Intraepithelial Neoplasia and the Impact of HIV Serostatus

CLINICAL PRESENTATION AND NATURAL HISTORY OF AIDS-RELATED KAPOSI'S SARCOMA

Pentoxifylline for the Treatment of Infection with Human Immunodeficiency Virus

1027MO ALKS 4230 monotherapy and in combination with pembrolizumab (pembro) in patients (pts) with refractory solid tumours (ARTISTRY-1)

The role of human immunodeficiency virus-I in the pathogenesis of acquired immunodeficiency syndrome-related Kaposi's sarcoma: the importance of an inflammatory and angiogenic milieu

Topacio: Preliminary activity and safety in patients (pts) with platinum-resistant ovarian cancer (PROC) in a phase 1/2 study of niraparib in combination with pembrolizumab

Fumagillin analog in the treatment of Kaposi's sarcoma : A phase I AIDS clinical trial group study

Cannabidiol inhibits growth and induces programmed cell death in kaposi sarcoma-associated herpesvirus-infected endothelium

17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023

Dose-finding combination study of niraparib and pembrolizumab in patients (pts) with metastatic triple-negative breast cancer (TNBC) or recurrent platinum-resistant epithelial ovarian cancer (OC) (TOPACIO/Keynote-162)

New therapies for the treatment of AIDS-related Kaposi sarcoma

Abstract PD5-02: Durability of clinical benefit with niraparib + pembrolizumab in patients with advanced triple-negative breast cancer beyond BRCA : (TOPACIO/Keynote-162)

Aktive Filter

Suchergebnisse filtern